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Is Kaposi's Sarcoma Induced by Retrovirus Infection? 
One very fascinating aspect of human biology is that certain patho-
logic processes present in different patient populations with differ-
ent onset, pace, outcome and even separate pathomechanisms. Ka-
posi's sarcoma (KS) is a histo logica lly distinctive malignancy that is 
found in several distinct clinical patterns: classical indolent KS in 
elderly J ewish men; the more aggressive endemic African KS, 
organ-transplant- associated KS, and aggressive epidemic KS in 
HN -1- infected patients. 
Immunosuppression is an important component of some of these 
presentations, and it has long been proposed that retrovirus infec-
tion may also have a direct role in inducing malignant transforma-
tion in KS . In this issue a multinational group headed by Georg 
Stingl report a detail ed histopathologic and immunopathologic in-
vesti.gation of endemic KS in the Southern Peloponnesus. This 
work provides new insights on this endemic focus ofKS and a better 
perspective on the cell of origin of KS. Finally, it leads us to infer 
chat such lesions are associated with an unidentified retrovirus. 
Epidemiologicall y this Mediterranean focus of KS is similar in 
incidence to endemic African KS, although the proportion of af-
fec ted fe males is greater than in endemic or cl ass ic KS. Clinically, 
the lesions in different stages on the hands and feet are similar to 
cl ass ical and endemic KS, whereas the widespread and "streaky" 
lesions, and especially the involvement of face, geni tal, mucosal, 
and gastrointestinal tract, are more similar to KS seen in patients 
with AIDS. Immunohistochemical and electronmicroscopic studies 
confirm that the cells lining the cleft-like lumina and forming the 
tumor bundles in the KS tumors are most likely oflymph atic endo-
thelial cell origin . Most importantl y, the authors identified in five of 
12 patients studied tubul ar-reticular structures and cylindrical con-
fronting cisternae within the KS cells and extracellular structures 
that strongly suggest the presence of a retrovirus. Serologic tests for 
antibodies to HIV -1, HIV -2, and HTL V -1 were consistently nega-
tive. Although ri gorous sea rching for known retroviral protein or 
amplification of retroviral genes has not yet been done, Dr. Stingl 
believes that these results force us to "entertain the possibility that 
th is represents a new re trovirus involved in the pathogenesis of 
Kaposi's sarcoma." The findin gs open many interesting possibilities 
of how different retroviruses in combination with host immuno-
logic and genetic fac tors might determine the very different clinical 
features of the variants of KS. 
Transforming Growth Factor Alpha and Malignant Transformation 
There is great interest in the complex multistage process of carcino-
genesis, and in the role of growth factors as mediators of malignant 
transformation. Many oncogenes code for growth fac tors or recep-
tor proteins for growth factors , and it has been proposed that auto-
crine effects of growth factors may be an important mechanism of 
mal ignant transformation. 
Eric Finzi of the Johns Hopkins University and his colleagues in 
the Laboratory of Cellular and Molecular Biology in the N ational 
Cancer Institute studied the autocrine effects of transforming 
growth factor C\' (TGF-C\') on fibroblas ts and keratinocyte cell lines . 
They constructed a retrovira l vector for TGF-C\' cDNA, and were 
able to produce cell lines that expressed TGF-C\' RNA and synthe-
sized and secreted TGF-C\'. However, none of the multiple fibrobl as t 
cell lines showed morphologic characteristics of malignant trans-
formation. They also used a keratinocyte line which was EGF de-
pendent. Because TGF-C\' and EGF activate the same receptor, it was 
reasoned that this would be an appropriate model for autocrine 
transformation b¥ TGF-C\'. Retroviral expression ofTGF-C\' in these 
cells was mitogenic, but failed to relieve the dependence of these 
cells on exogenous EGF. 
Dr. Finzi notes that some growth factors, such as platelet-derived 
growth factor (PDGF), have autocrine transforming activity in 
some tissues, and that increased expression of the EGF receptor is 
seen in some squamous cell carcinomas. In addition, another labora-
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tory has shown that autocrine production ofTGF-a is sufficient to 
transform a fibroblast cell line. 
"How the growth factor is processed in a particular tissue may be 
crucial in determining transforming activity," explained Dr. Finzi. 
He surmised that levels of receptor, partitioning of growth factor, 
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degradation of the growth factor, and interference ofligand/recep-
tor binding may all influence the ability of exogenous growth fac-
tors to effect malignant transformation. The process of malignan 
transformation promises to be complex, with no single trigger or 
simple common pathway. 
What is Porakeratosis? 
The porokeratoses have distinctive clinical and pathologic findings , 
but unknown etiologies. It has been proposed that the porokeratoses 
represent a clonal growth of epidermal cells. It should be possible to 
test this hypothesis using modern techniques of cellular and molecu-
lar biology. 
In this issue Alice Ma and her collaborators at the University of 
Chicago have identified some unusual characteristics of porokera-
tosis that raise further questions of the nature of this distinctive 
clinical pattern. Five patients with porokeratosis were studied using 
modern techniques to identify matrix protein patterns in lesional 
skin, and to study the growth of epidermal cells and the pattern of 
keratin production from these patients. Interestingly, type IV colla-
gen was identified in the patients' stratum corneum by immunohis-
tochemistry, and positive intraepidermal staining of laminin and 
type IV collagen implied the transepidermal passage of basement 
membrane components in porokeratosis lesions. Epidermal cells 
plated from lesions showed unusual characteristics of growth in . 
cuI ture and also demonstrated a keratin not normall y seen in normal 
glabrous skin. 
Dr. Ma feels that the findings support the hypothesis that poro-
keratosis represents an unusual proliferation of ductal epithelial ce.lls 
with associated abnormal patterns of basement membrane compo-
nents. Although the unusual characteristics of the cultured epithe-
lial cells "may represent clonal proliferation," she noted "further 
work using modern molecular techniques is necessary to determine 
true clonality of the proliferating cells ." This is another example of 
how modern investigative techniques can be effectively applIed 
clinical problems of disordered epidermal growth and differentia-
tion. 
Proteolysis in the Stratum Corneum 
Cohesion of the cells in the stratum corneum is crucial to mainte-
nance of the epidermal barrier, and conversely the desquamation of 
these cells is an important biologic process that we are just begin-
ning to understand. Torbjorn Egelrud and Anita Lundstrom from 
the University of Umea have previously shown that cell dissocia-
tion from plantar skin is associated with degradation of the desmo-
somal protein desmoglein 1. Their work supports the contention 
th at endogenous proteolytic activity degrades DGI and perhaps 
other adherence structures. In this issue they extend these findings 
to non-plantar skin, demonstrating that detergent-induced dissocia-
tion of cells from the stratum corneum, but not from spinous or 
basal layers of the epidermis, is prevented by the protease inhibitor 
aprotinin. The authors conclude from this model system that pro-
/ 
tein structures are crucial for maintenance of stratum corneum integ-
rity and that the action of local endogenous proteases mediates the 
cell dissociation that occurs during desquamation. 
An active proteolytic environment in the stratum corneum may 
also influence other important biologic functions besides desqua-
mation. Epidermal keratinocytes produce many important cyro-
kines that can be secreted or displayed in the cell membrane. Some, 
such as IL-l/l, require proteolytic degradation for activation. It is 
intriguing to wonder whether such cytokines are activated by prote-
olysis in the stratum corneum, and what might be the activity an 
specificity of this proteolytic environment in diseases such as psori-
aSIS. 
